Marianna Vachalcova

Dr. Marianna Vachalcova


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
ABAllan Böhm
Allan Böhm
MVMarianna Vachalcova
Marianna Vachalcova
PSPeter Snopek
Peter Snopek
LBLjuba Bacharova
Ljuba Bacharova
DKDominika Komarova
Dominika Komarova
RHRobert HATALA
Robert HATALA
Micro ribonucleic acids (miRNAs) are short non-coding RNA molecules responsible for regulation of gene expression. They are involved in many pathophysiological processes of a wide spectrum of diseases. Recent studies showed their involvement in atrial fibrillation. They seem to become potential screening biomarkers for atrial fibrillation and even treatment targets for this arrhythmia. The aim of this review article was to summarize the latest knowledge about miRNA and their molecular relation to the pathophysiology, diagnosis and treatment of atrial fibrillation.

14 March 2016 in Wiener klinische Wochenschrift
Verified
Journal Article
Closed access
PDF file
IVIvana Valocikova
Ivana Valocikova
MVMarianna Vachalcova
Marianna Vachalcova
GVGabriel Valocik
Gabriel Valocik
MKMarian Kurecko
Marian Kurecko
MDMariana Dvoroznakova
Mariana Dvoroznakova
DHDusan Holoubek
Dusan Holoubek

2 August 2023 in Wiener klinische Wochenschrift
Verified
Journal Article
Open access
PDF file
ŠTŠtefan Tóth
Štefan Tóth
MVMarianna Vachalcova
Marianna Vachalcova
DKDávid Kaško
Dávid Kaško
MTMartin Turek
Martin Turek
ZGZuzana Guľašová
Zuzana Guľašová
ZHZdenka Hertelyová
Zdenka Hertelyová
Summary: Significant acute cardiovascular, metabolic, and endocrine changes have been traced to short-lasting cold water immersion (CWI); however, the long-term impact of recurrent CWI on atherogenesis, lipid parameters, and fat distribution has not yet been studied. The goal of this study was to investigate the alleged protective effect. A total of 35 healthy volunteers were monitored for a period of 5 months during which the CWI was performed under standardized conditions (three times per week for 7–10 min, without neoprene equipment). Volunteers with measured weight or muscle mass increases of more than 5% were ineligible. An analogous control group (N = 30) was included. At the onset and completion of the study, blood samples were obtained, and clinical assessments took place. PCSK9 and hsCRP levels were measured together with other lipid-related and non-lipid-related indicators. Carotid intima-media thickness test (cIMT) and echo-tracking for the identification of arterial stiffness (PWV, AI, and β) were used to identify early vascular alterations. Hepatorenal index (HRI) calculations served to quantify liver steatosis, while changes in subcutaneous and visceral fat thickness were used to quantify fat distribution. The given protocol was successfully completed by 28 volunteers. Long-term repeated CWI resulted in a significant decline in cIMT (p = 0.0001), AI (p = 0.0002), Beta (p = 0.0001), and PWV (p = 0.0001). PCSK9 (p = 0.01) and hsCRP (p = 0.01) showed a significant decrease when compared to initial values. In comparison to the starting values, liver fat accumulation decreased by 11% on average (HRI p = 0.001). LDL, TC, TG, and VLDL levels all significantly decreased as well. We suggest that repeated CWI may have beneficial impact on lipid, non-lipid, and lipid-related indices, as well as atherogenesis and liver fat storage.

1 January 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
ŠTŠtefan Tóth
Štefan Tóth
MVMarianna Vachalcova
Marianna Vachalcova
KBKamil Barbierik
Kamil Barbierik
AJAdriana Jarolimkova
Adriana Jarolimkova
PFPavol Fülöp
Pavol Fülöp
TPTibor Poruban
Tibor Poruban
Background/Objectives: Cardiovascular (CV) diseases remain the leading cause of morbidity and mortality across Europe. Despite substantial progress in prevention, diagnostics, and therapeutics, outpatient cardiology care continues to face systemic challenges, including limited consultation time, workforce constraints, and incomplete clinical information at the point of care. The primary objective of this study is threefold. First, to evaluate whether AI-enhanced telemedicine improves clinical control of hypertension, dyslipidemia, and heart failure compared to standard ambulatory care. Second, to assess the impact on physician workflow efficiency and documentation burden through AI-assisted clinical documentation. Third, to determine patient satisfaction and safety profiles of integrated telemedicine–AI systems. Clinical control will be measured by a composite endpoint of disease-specific targets assessed at the 12-month follow-up visit. Methods: The TeleAI-CVD Concept Study aims to evaluate the integration of telemedicine and artificial intelligence (AI) to enhance the efficiency, quality, and individualization of cardiovascular disease management in the ambulatory setting. Within this framework, AI-driven tools will be employed to collect structured clinical histories and current symptomatology from patients prior to outpatient visits using digital questionnaires and conversational interfaces. Results: Obtained data, combined with telemonitoring metrics, laboratory parameters, and existing clinical records, will be synthesized to support clinical decision-making. Conclusions: This approach is expected to streamline consultations, increase diagnostic accuracy, and enable personalized, data-driven care through continuous evaluation of patient trajectories. The anticipated outcomes of the TeleAI-CVD study include the development of optimized, AI-assisted management protocols for cardiology patients, a reduction in unnecessary in-person visits through effective telemedicine-based follow-up, and accelerated attainment of therapeutic targets. Ultimately, this concept seeks to redefine the paradigm of outpatient cardiovascular care by embedding advanced digital technologies within routine clinical workflows.

12 June 2024 in Archives of Medical Science
Verified
Journal Article
Open access
DPDominik Pella
Dominik Pella
TPTibor Poruban
Tibor Poruban
JGJozef Gonsorcik
Jozef Gonsorcik
JFJan Fedacko
Jan Fedacko
Zuzana PellaZuzana Pella
Zuzana Pella
MVMarianna Vachalcova
Marianna Vachalcova
Introduction: The growing interest in Vitamin D deficiency as a potential contributor to coronary artery disease (CAD) has prompted increased scrutiny. Nevertheless, its status as a confirmed risk factor remains unestablished. This study seeks to explore the connection between serum vitamin D levels and CAD.Material and methods: Employing a cross-sectional approach, 205 patients eligible for coronary computed tomography angiography (CCTA) were chosen. Serum vitamin D levels were assessed and juxtaposed with the outcomes of CCTA, which encompassed the coronary artery calcium score (CACS), as well as the presence and severity of coronary artery involvement attributed to atherosclerotic plaques.Results: The average age of the participants was 61.4±10.8 years, and the mean serum vitamin D level was 19.6±10.3 ng/dl (ranging from 4.7 to 39.7 ng/dl). In total, 52.1% of the participants (n=107) exhibited vitamin D deficiency, 35.1% (n=72) had insufficient levels, and 12.6% (n=26) had sufficient levels of vitamin D. The mean serum vitamin D level was notably lower in patients with severe coronary artery disease (CAD) (P<0.0001). According to the Spearman test, a significant negative correlation (-0.48) was identified between the serum vitamin D level and CACS (P<0.0001). Conversely, the mean CACS in the vitamin D deficient group was significantly higher than in the insufficient and sufficient vitamin D groups (P<0.0001 for both comparisons).Conclusions: There was a correlation between vitamin D deficiency and both CACS and the severity of coronary artery stenosis.

27 June 2024 in Diagnostics
Verified
Journal Article
Open access
PDF file
JJJakub Jurica
Jakub Jurica
MPMartin Jozef Péč
Martin Jozef Péč
MCMarek Cingel
Marek Cingel
TBTomáš Bolek
Tomáš Bolek
MVMarianna Vachalcova
Marianna Vachalcova
MSMatej Samos
Matej Samos
Aims: The aims of this study were to compare global longitudinal strain of the left ventricle (LV-GLS) and reservoir strain of the left atrium (R-LAS) values between patients with acute decompensation of chronic heart failure (HF) and a control group. Methods: Sixteen patients admitted to our ward for acute decompensation of HF were enrolled in this study. Transthoracic echocardiography (TTE) with two-dimensional speckle-tracking analysis (2D ST) was performed in each patient. The patients were divided into two subgroups according to the value of left ventricular ejection fraction (EF) using a cut-off value of ≤40% to distinguish heart failure with reduced ejection fraction (HFrEF) from heart failure with preserved ejection fraction (HFpEF). The control group consisted of 16 individuals without a history of cardiovascular disease, each of whom underwent 2D ST analysis as well. Results: We found that LV-GLS and R-LAS were significantly lower in both the HFrEF and HFpEF subgroups in comparison with the control group (LV-GLS: −13.4 ± 4.7% vs. −19.7 ± 2.5%, p ˂ 0.05; R-LAS: +12.2 ± 6.9% vs. +40.3 ± 7.4%, p ˂ 0.05). Furthermore, there was a significant difference in LV-GLS (−9.6 ± 3.2% vs. −15.2 ± 4.3%, p ˂ 0.05) but not in R-LAS (+13.7 ± 8.6% vs. +11.4 ± 6.2%) between the HFrEF and HFpEF subgroups. Conclusions: Our study demonstrated a significant difference in LV-GLS and R-LAS in all enrolled HF patients compared to the control group. There was also a significant difference in LV-GLS between the HFrEF and HFpEF subgroups.